Related Experiment Video
Updated: Aug 9, 2026

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
Published on: November 17, 2020
Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis
S Sriram1, C W Stratton, S Yao
1Department of Neurology, Vanderbilt School of Medicine, Nashville, TN, USA.
Abstract:
Our identification of Chlamydia pneumoniae in the cerebrospinal fluid (CSF) of a patient with multiple sclerosis (MS) led us to examine the incidence of this organism in the CSF from 17 patients with relapsing-remitting MS, 20 patients with progressive MS, and 27 patients with other neurological diseases (OND). CSF samples were examined for C pneumoniae by culture, polymerase chain reaction assays, and CSF immunoglobulin (Ig) reactivity with C pneumoniae elementary body antigens. C pneumoniae was isolated from CSF in 64% of MS patients versus 11% of OND controls. Polymerase chain reaction assays demonstrated the presence of C pneumoniae MOMP gene in the CSF of 97% of MS patients versus 18% of OND controls. Finally, 86% of MS patients had increased CSF antibodies to C pneumoniae elementary body antigens as shown by enzyme-linked immunosorbent assay absorbance values that were 3 SD greater than those seen in OND controls. The specificity of this antibody response was confirmed by western blot assays of the CSF, using elementary body antigens. Moreover, CSF isoelectric focusing followed by western blot assays revealed cationic antibodies against C pneumoniae. Infection of the central nervous system with C pneumoniae is a frequent occurrence in MS patients. Although the organism could represent the pathogenetic agent of MS, it may simply represent a secondary infection of damaged central nervous system tissue. A therapeutic trial directed at eliminating C pneumoniae from the central nervous system may provide additional information on its role in MS.
Insights
Chlamydia pneumoniae was frequently detected in cerebrospinal fluid (CSF) of multiple sclerosis (MS) patients, suggesting a potential role in the disease. Further research is needed to determine if this bacterium causes MS or is a secondary infection.
Area of Science:
- Neuroscience
- Infectious Diseases
- Microbiology
Background:
- Multiple sclerosis (MS) is a chronic neurological disease with an unclear etiology.
- Chlamydia pneumoniae is a bacterium that has been investigated for its potential role in various chronic diseases.
Purpose of the Study:
- To investigate the incidence of Chlamydia pneumoniae in the cerebrospinal fluid (CSF) of patients with multiple sclerosis (MS) compared to other neurological diseases (OND).
- To explore the potential association between C. pneumoniae infection and the pathogenesis of MS.
Main Methods:
- CSF samples from MS patients (relapsing-remitting and progressive) and OND patients were analyzed.
- Detection methods included C. pneumoniae culture, polymerase chain reaction (PCR) for the MOMP gene, and CSF immunoglobulin (Ig) reactivity assays (ELISA, Western blot).
Main Results:
- C. pneumoniae was isolated from 64% of MS patients versus 11% of OND controls.
- PCR detected C. pneumoniae MOMP gene in 97% of MS patients compared to 18% of OND controls.
- 86% of MS patients showed increased CSF antibodies to C. pneumoniae elementary body antigens.
Conclusions:
- Infection of the central nervous system with Chlamydia pneumoniae is common in MS patients.
- C. pneumoniae may be a causative agent of MS or a secondary invader in damaged CNS tissue.
- A therapeutic trial targeting C. pneumoniae in the CNS could clarify its role in MS pathogenesis.
Related Concept Videos
Atypical Pneumonia
Cryptococcal Meningitis
Bacterial Meningitis I: Introduction
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Multiple Sclerosis l: Introduction

